New Treatment Options for Relapsed/Recurrent DLBCL: Impact on Sequencing Therapeutic Choices - Episode 10

Management of CRS and ICANS with CAR T-cell Therapy

, , ,

A panel of experts discuss the incidence, severity, and management of AEs associated with CAR Tcell therapy.

Video content above is prompted by the following:

  • Please discuss the incidence, severity, and management of AEs associated with CAR Tcell therapy, particularly CRS and ICANS?